Tarsus Pharmaceuticals, Inc. business relationships
Companies named in Tarsus Pharmaceuticals, Inc.’s 10-K filed 2026-02-23, and public companies whose annual reports name Tarsus Pharmaceuticals, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 70 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Tarsus Pharmaceuticals, Inc.’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name Tarsus Pharmaceuticals, Inc. 1
“...the U.S. of XDEMVY ® (lotilaner ophthalmic solution) 0.25 % , a medical treatment for Demodex blepharitis in humans, by Tarsus Pharmaceuticals, Inc. (Tarsus) and (b) certain future sales milestone payments we are owed based on global net sales of XDEMVY, both of which are pursuant to the terms of a...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.